However, ibrutinib treatment markedly suppressed their levels (Figure 5A–H), implying that ibrutinib alleviates poly I:C- and LPS-induced ALI by suppressing IL-1β, TNF-α, and neutrophil aggregation levels. Here, IL1B is linked to acute respiratory distress syndrome.